Second-line therapy with nivolumab plus ipilimumab for older patients with oesophageal squamous cell cancer (RAMONA): a multicentre, open-label phase 2 trial
Titel:
Second-line therapy with nivolumab plus ipilimumab for older patients with oesophageal squamous cell cancer (RAMONA): a multicentre, open-label phase 2 trial
Auteur:
Ebert, Matthias P Meindl-Beinker, Nadja M Gutting, Tobias Maenz, Martin Betge, Johannes Schulte, Nadine Zhan, Tianzuo Weidner, Philip Burgermeister, Elke Hofheinz, Ralf Vogel, Arndt Angermeier, Stefan Bolling, Claus de Wit, Maike Jakobs, Ralf Karthaus, Meinolf Stocker, Gertraud Thuss-Patience, Peter Leidig, Tobias Gaiser, Timo Kather, Jakob N Haertel, Nicolai
Verschenen in:
Lancet. Healthy longevity
Paginering:
Jaargang 3 () nr. 6 pagina's e417-e427
Jaar:
2022
Inhoud:
Uitgever:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license